Cita APA

Osinski, V., Bauknight, D. K., Dasa, S. S. K., Harms, M. J., Kroon, T., Marshall, M. A., . . . McNamara, C. A. (2020). In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects. Theranostics.

Chicago Style Citation

Osinski, Victoria, et al. "In Vivo Liposomal Delivery of PPARα/γ Dual Agonist Tesaglitazar in a Model of Obesity Enriches Macrophage Targeting and Limits Liver and Kidney Drug Effects." Theranostics 2020.

Cita MLA

Osinski, Victoria, et al. "In Vivo Liposomal Delivery of PPARα/γ Dual Agonist Tesaglitazar in a Model of Obesity Enriches Macrophage Targeting and Limits Liver and Kidney Drug Effects." Theranostics 2020.